Welcome!
To use the personalized features of this site, please log in or register.
If you have forgotten your username or password, we can help.
|
 |
Computational Approaches to Drug Design
| |
|
Computational Approaches to Drug Design
P. W. Finn1 and L. E. Kavraki2
| (1) |
Pfizer Central Research, Sandwich, Kent, England. Author's current address: Prolofix Ltd., 91 Milton Park, Milton, Oxfordshire,
England., UK |
| (2) |
Department of Computer Science, Rice University, Houston, TX 77005, USA. kavraki@cs.rice.edu., US |
Abstract. The rational approach to pharmaceutical drug design begins with an investigation of the relationship between chemical structure
and biological activity. Information gained from this analysis is used to aid the design of new, or improved, drugs. Primary
considerations during this investigation are the geometric and chemical characteristics of the molecules. Computational chemists
who are involved in rational drug design routinely use an array of programs to compute, among other things, molecular surfaces
and molecular volume, models of receptor sites, dockings of ligands inside protein cavities, and geometric invariants among
different molecules that exhibit similar activity. There is a pressing need for efficient and accurate solutions to the above
problems. {Often, limiting assumptions need to be made, in order to make the calculations tractable. Also,} the amount of
data processed when searching for a potential drug is currently very large and is only expected to grow larger in the future.
This paper describes some areas of computer-aided drug design that are important to computational chemists but are also rich
in algorithmic problems. It surveys recent work in these areas both from the computational chemistry and the computer science
literature.
Key words. Computer-assisted pharmaceutical drug design, Molecular surfaces, Conformational search, Pharmacophore identification.
Received June 5, 1997; revised June 20, 1998.
Fulltext Preview (Small, Large)
|
|
|
|
|
|